Summary
The action of watery rat gut extracts on glucose-induced insulin release in anaesthetized rats was examined before and after removal of GIP by immunoadsorption. Infusions of GIP-containing rat gut extracts nearly doubled the insulin release induced by intravenous glucose (1g · kg−1 · h−1). Peak insulin secretion was 98±11 mU/l (mean±SEM) after intravenous glucose and increased to 178±16 mU/l following infusion of glucose plus gut extract (p<0.005). After injection of GIP antiserum in sufficient amounts to neutralize the GIP activity in the gut extract preparation, the additional insulin release due to the gut extract was reduced by only 30%. After complete removal of GIP from gut extracts by immunoabsorption, more than 50% of the incretin effect remained. These data suggest that the insulinotropic activity of rat gut extracts can only be partially related to GIP. The existence of additional insulinotropic gut factors which may also be released following oral glucose is postulated.
Article PDF
Similar content being viewed by others
References
La Barre J, Still EU (1930) Studies on the physiology of secretin. III. Further studies on the effects of secretin on the blood sugar. Am J Physiol 91: 649–653
McIntyre C, Holdsworth CD, Turner DS (1964) New interpretation of oral glucose tolerance. Lancet 2: 20–21
Elrick H, Stimmler L, Hlad CJ, Arai Y (1964) Plasma insulin responses to oral and intravenous glucose administration. J Clin Endocrinol Metab 24: 1076–1082
Dupré J (1964) An intestinal hormone affecting glucose disposal in man. Lancet 2: 672–673
Unger RH, Eisentraut AM (1969) Entero-insular axis. Arch Intern Med 123: 261–266
Creutzfeldt W (1979) The incretin concept today. Diabetologia 16: 75–85
Dupré J, Ross SA, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 37: 826–828
Rabinovitch A, Dupré J (1974) Effects of gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat. Endocrinology 94: 1139–1144
Schauder P, Brown JC, Frerichs H, Creutzfeldt W (1975) Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro. Diabetologia 11: 483–484
Pederson RA, Brown JC (1976) The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology 99: 780–785
Brown JC, Dryburgh JR, Ross SA, Dupré J (1975) Identification and actions of gastric inhibitory polypeptide. Recent Progr Horm Res 31: 487–532
Lauritsen KB, Holst JJ, Moody AJ (1981) Depression of insulin release by anti-GIP serum after oral glucose in rats. Scand J Gastroenterol 16: 417–421
Ebert R, Creutzfeldt W (1982) Influence of GIP antiserum on glucose-induced insulin secretion in rats. Endocrinology 111: 1601–1606
Porte, D Jr, Girardier L, Seydoux J, Kanazawa Y, Posternak Y (1973) Neural regulation of insulin secretion in the dog. J Clin Invest 52: 210–214
Fischer U, Hommel H, Ziegler M, Jutzi E (1972) The mechanism of insulin secretion after oral glucose administration. III. Investigations on the mechanism of a reflectoric insulin mobilization after oral stimulation. Diabetologia 8: 385–390
Steinbuch M, Audran R (1969) The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 134: 279–284
Akanuma Y, Kuzya T, Hayashi M, Ide T, Kuzuya N (1970) Immunological reactivity of insulin to sepharose coupled with insulin-antibody — its use for the extraction of insulin from serum. Biochem Biophys Res Commun 5: 947–953
Melani F, Ditschuneit H, Bartelt KM, Friedrich H, Pfeiffer EF (1965) Über die radioimmunologische Bestimmung von Insulin im Blut. Klin Wochenschr 43: 1000–1006
Kuzio M, Dryburgh JR, Malloy KM, Brown JC (1974) Radioimmunoassay for gastric inhibitory polypeptide. Gastroenterology 66: 357–364
Creutzfeldt W, Ebert R, Willms B, Frerichs H, Brown JC (1978) Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia 14: 15–24
Ebert R, Illmer K, Creutzfeldt W (1979) Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect by GIP-antiserum in rats. Gastroenterology 76: 515–523
Flaten O (1981) Radioimmunoassay of gastric inhibitory polypeptide (GIP) and the effect of intraduodenal acidification on glucose-stimulated and unstimulated GIP release in humans. Scand J Gastroenterol 16: 545–554
Finke U, Ebert R, Creutzfeld W (1978) Different forms of immunoreactive gastric inhibitory polypeptide (IR-GIP) in human serum and intestinal mucosa. Diabetologia 15: 232 (Abstract)
Gespach C, Bataille D, Jarousse C, Rosselin G (1979) Ontogeny and distribution of immunoreactive gastric inhibitory polypeptide (IR-GIP) in rat small intestine. Acta Endocrinol 90: 307–316
Goyal RK, McGuigan JE (1976) Is gastrin a major determinant of basal lower esophageal sphincter pressure? J Clin Invest 57: 291–298
Siegel EG, Trimble ER, Renold AE, Berthoud HR (1980) The imortance of preabsorptive insulin release on oral glucose tolerance: studies in pancreatic islet transplanted rats. Gut 21: 1002–1009
Woods SC, Porte D Jr (1974) Neural control of the endocrine pancreas. Physiol Rev 54: 596–619
Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R (1978) Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 62: 152–161
Rehfeld JF, Stadil F (1973) The effect of gastrin on basal and glucose stimulated insulin secretion in man. J Clin Invest 52: 1415–1426
Hayes JR, Ardill J, Buchanan KD (1975) Gastrin and insulin release. Diabetologia 11: 89–92
Turner DS, Etheridge L, Marks V, Brown JC, Mutt V (1974) Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat. Diabetologia 10: 459–463
Fahrenkrug J, Schaffalitzky de Muckadell OB, Kühl C (1978) Effect of secretin on basaland glucose-stimulated insulin secretion in man. Diabetologia 14: 229–234
Jensen SL, Rehfeld JF, Holst JJ, Nielsen OV, Fahrenkrug J, Schaffalitzky de Muckadell, OB (1981) Secretory effects of cholecystokinins on the isolated perfused porcine pancreas. Acta Physiol Scand 111: 225–231
Moody AJ (1977) Insulin releasing polypeptides. In: Bajaj JS (ed) Diabetes, Internationel Congress Series 413. Excerpta Medica, Amsterdam, pp 76–82
Turner DS, Shabaam A, Etheridge L, Marks V (1973) The effect of an intestinal polypeptide fraction on insulin release in the rat in vitro and in vivo. Endocrinology 93: 1325–1328
Zermatten A, Felber J-P (1974) Sensitivity to glucose of an intestial factor stimulating insulin release. Horm Metab Res 6: 272–274
Levin SR, Phelevanian MZ, Lavee AE, Adachi RI (1979) Secretion of an insulinotropic factor from the isolated, perfused rat intestine. Am J Physiol 236: E710-E720
Sarson DL, Wood SM, Holder D, Bloom SR (1982) The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man. Diabetologia 22: 33–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ebert, R., Unger, H. & Creutzfeldt, W. Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia 24, 449–454 (1983). https://doi.org/10.1007/BF00257346
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00257346